semaglutide cardiovascular outcomes news today HUGE NEWS! Contrary to popular belief: GLP-1 weight loss medications are NOT all about aesthetics, they REDUCE risk of death, heart attack, stroke, heart failure, AND ALL CAUSE MORTALITY! Groundbreaking SELECT Semaglutide and Cardiovascular Outcomes in
Description
Trial registry entries on clinicaltrials.gov (TRIUMPH-1: NCT05929066

Your doctor will assess your medical history to determine if youre a proper candidate and which medication will be best for you.

Compounding access may be limited for patients, particularly in areas with ambiguous regulations
Comment or DM if you want in

Based on this information, Novo Nordisk may decide to ask for a payment or request additional information

2 (2024): e156, 10.1097/JW9.0000000000000156
